A Phase 1a/1b Trial Of St-001, A Fenretinide Phospholipid Suspension For 4-Hour Intravenous Infusion In Relapsed/ Refractory T-Cell Non-Hodgkin'S Lymphoma

BLOOD(2019)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要